SHRX — Sharp Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapMomentum Trap

Annual balance sheet for Sharp Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS
Status:	fx Final	fx Final	fx Final	Final
Cash
Cash and Short Term Investments	0.063	0.111	0.299	3.48
Net Total Receivables	—	0.004	0	—
Prepaid Expenses
Total Other Current Assets
Total Current Assets	0.063	0.125	0.299	3.52
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	—	—	—	1.02
Other Long Term Assets
Total Assets	0.063	0.125	0.299	4.55
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	0.074	0.034	0.019	0.69
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Liabilities	0.074	0.034	0.019	1.97
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	-0.011	0.091	0.28	2.58
Total Liabilities & Shareholders' Equity	0.063	0.125	0.299	4.55
Total Common Shares Outstanding